FDA inspection
Novartis Pharma Produktions GmbH: FDA inspection ending May 19, 2017
FDA inspection 1015619 · No Action Indicated (NAI) · Wehr
Key facts
| Inspection ID | 1015619 |
|---|---|
| Firm | Novartis Pharma Produktions GmbH |
| FEI number | 3000978864 |
| Address | Oflinger Str. 44 |
| City | Wehr |
| Country | Germany |
| Fiscal year | 2017 |
| Inspection end date | May 19, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data